Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-06

Clinical Trial Update: Comparative Study Between Oral Liposomal Iron,Iron Supported Lactoferrin and IV Iron Dextran in CKD Children [Phase 4]

View source ↗

Summary

A phase 4 comparative trial in children with chronic kidney disease comparing oral liposomal iron, iron-supported lactoferrin, and IV iron dextran.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IV iron dextran (iron dextran)
  • Oral liposomal iron (liposomal iron)
  • iron-supported lactoferrin (lactoferrin iron complex)

Snippet

Sponsor: Menoufia University | Conditions: CKD - Chronic Kidney Disease | Phase 4 | Status: UNKNOWN